Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Kinzler

Showing results (221-230 of 282) with videos related to

Pageof 29
Sort By:
Nature Communications|June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancerYujun Hao, Yardena Samuels, Qingling Li, et al.
Cancer Research|April 9, 2009
Genetic mutations associated with cigarette smoking in pancreatic cancerAmanda Blackford, Giovanni Parmigiani, Thomas W Kensler, et al.
Nature Communications|August 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigenKatharine M Wright, Sarah R DiNapoli, Michelle S Miller, et al.
Journal for Immunotherapy of Cancer|August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkersJarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
Oncotarget|April 18, 2013
Exomic sequencing of four rare central nervous system tumor typesChetan Bettegowda, Nishant Agrawal, Yuchen Jiao, et al.
Nature Communications|September 7, 2021
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigensMichael S Hwang, Michelle S Miller, Puchong Thirawatananond, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2008
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancersRebecca J Leary, Jimmy C Lin, Jordan Cummins, et al.
Science Translational Medicine|July 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densitiesBrian J Mog, Nikita Marcou, Sarah R DiNapoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancerAmanda Blackford, Oscar K Serrano, Christopher L Wolfgang, et al.
Pageof 29

Showing results (221-230 of 282) with videos related to

Sort By:
Pageof 29
Nature Communications|June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancerYujun Hao, Yardena Samuels, Qingling Li, et al.
Cancer Research|April 9, 2009
Genetic mutations associated with cigarette smoking in pancreatic cancerAmanda Blackford, Giovanni Parmigiani, Thomas W Kensler, et al.
Nature Communications|August 21, 2023
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigenKatharine M Wright, Sarah R DiNapoli, Michelle S Miller, et al.
Journal for Immunotherapy of Cancer|August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkersJarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
Oncotarget|April 18, 2013
Exomic sequencing of four rare central nervous system tumor typesChetan Bettegowda, Nishant Agrawal, Yuchen Jiao, et al.
Nature Communications|September 7, 2021
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigensMichael S Hwang, Michelle S Miller, Puchong Thirawatananond, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2008
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancersRebecca J Leary, Jimmy C Lin, Jordan Cummins, et al.
Science Translational Medicine|July 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densitiesBrian J Mog, Nikita Marcou, Sarah R DiNapoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancerAmanda Blackford, Oscar K Serrano, Christopher L Wolfgang, et al.
Pageof 29